QIAGEN NV (QGEN)
45.85
+0.29
(+0.64%)
USD |
NYSE |
Dec 10, 15:39
QIAGEN Profit Margin (Quarterly): 24.42% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| InflaRx NV | -51.54K% |
| CDT Equity, Inc. | -- |
| LENZ Therapeutics, Inc. | -133.6% |
| Liminatus Pharma, Inc. | -- |
| Oruka Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.48% |
| Return on Assets | 6.78% |
| Return on Invested Capital | 7.77% |
| Gross Profit Margin (Quarterly) | 61.80% |
| Operating Margin (Quarterly) | 25.78% |
| Return on Net Operating Assets | 9.38% |